We are live on ! Find out more
RKDA icon

Arcadia Biosciences
RKDA

14 hedge funds and large institutions have $1.47M invested in Arcadia Biosciences in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 4

17% more funds holding

Funds holding: 12 → 14 (+2)

9% more capital invested

Capital invested by funds: $1.35M → $1.47M (+$122K)

0.09% more ownership

Funds ownership: 0.1% → 0.19% (+0.09%)

Holders
14
Holders Change
+2
Holders Change %
+16.67%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$718K
2
Morgan Stanley
Morgan Stanley
New York
+$433K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$199K
4
SM
Sabby Management
Florida
+$107K
5
Renaissance Technologies
Renaissance Technologies
New York
+$83.4K

Top Sellers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$161K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$74K
3
UBS Group
UBS Group
Switzerland
-$66K
4
SWM
SeaCrest Wealth Management
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$414K +$718K +3,377 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$359K +$199K +937 +47%
Morgan Stanley
3
Morgan Stanley
New York
$250K +$433K +2,037 +203,700%
Bank of Montreal
4
Bank of Montreal
Ontario, Canada
$123K – – –
VF
5
Virtu Financial
New York
$61K +$32.5K +153 +44%
SM
6
Sabby Management
Florida
$61K +$107K +501 New
Renaissance Technologies
7
Renaissance Technologies
New York
$48K +$83.4K +392 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$42K – – –
Cambridge Investment Research Advisors
9
Cambridge Investment Research Advisors
Iowa
$34K +$58.5K +275 New
Deutsche Bank
10
Deutsche Bank
Germany
$33K +$57.8K +272 +9,067%
Citadel Advisors
11
Citadel Advisors
Florida
$32K +$55.9K +263 New
Wells Fargo
12
Wells Fargo
California
$8K +$13.4K +63 New
AG
13
Advisor Group
Arizona
$6K – – –
BlackRock
14
BlackRock
New York
$1K – – –
Dimensional Fund Advisors
15
Dimensional Fund Advisors
Texas
– -$161K -574 Closed
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
– -$74K -266 Closed
UBS Group
17
UBS Group
Switzerland
– -$66K -234 Closed
SWM
18
SeaCrest Wealth Management
New York
– -$3K -11 Closed

RKDA Hedge Fund Activity: Q2 2019 in Review

14 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q2 2019, worth a combined $1.47M — up 9% from $1.35M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new RKDA positions and 4 closed out — a net gain of 2 holders — while 4 added to existing stakes and 0 trimmed.

The largest buyer was CVI Holdings, opening a new position worth an estimated $718K. The largest seller was Dimensional Fund Advisors, exiting entirely with an estimated $161K sold.

  • 14 institutional investors held Arcadia Biosciences (RKDA) as of Q2 2019, up from 12 in Q1 2019.
  • Funds reported $1.47M of Arcadia Biosciences stock for Q2 2019, up 9% quarter-over-quarter.
  • 6 funds opened new Arcadia Biosciences positions in Q2 2019 and 4 closed out, a net change of +2 holders.
  • The largest Arcadia Biosciences buyer in Q2 2019 was CVI Holdings, an estimated $718K added.
  • The largest Arcadia Biosciences seller in Q2 2019 was Dimensional Fund Advisors, an estimated $161K sold.

Based on aggregated 13F filings for Q2 2019.